Actividad in vitro de la combinación de ceftarolina con otros antimicrobianos activos frente a Staphylococcus spp
Gil Romero, Yolanda; Gómez-Garcés, José-Luis.
Enferm. infecc. microbiol. clín. (Ed. impr.)
; 38(1): 25-27, ene. 2020. tab
Artículo en Español | IBECS (España) | ID: ibc-200430
Documentos relacionados
Analysis of synergy between beta-lactams and anti-methicillin-resistant Staphylococcus aureus agents from the standpoint of strain characteristics and binding action.
In vitro activity of daptomycin combined with dalbavancin and linezolid, and dalbavancin with linezolid against MRSA strains.
Delafloxacin activity against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid.
In vitro activity of fosfomycin alone and in combination against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid.
In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus.
<i>In Vitro</i> Synergistic Effect of Vancomycin and Some Antibacterial Agents Against Clinical Methicillin-Resistant and Sensitive <i>Staphylococcus aureus</i> Isolates.
A study on combination of daptomycin with selected antimicrobial agents: in vitro synergistic effect of MIC value of 1 mg/L against MRSA strains.
Anti-mutant efficacy of antibiotic combinations: in vitro model studies with linezolid and daptomycin.
Antimicrobial Synergistic Effects of Linezolid and Vancomycin with a Small Synthesized 2-Mercaptobenzothiazole Derivative: A Challenge for MRSA Solving.
In vitro activity of ceftaroline in combination with other antimicrobials active against Staphylococcus spp.